IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORUCCI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.781
EU - Europa 12.206
AS - Asia 11.564
SA - Sud America 2.171
Continente sconosciuto - Info sul continente non disponibili 905
AF - Africa 315
OC - Oceania 16
Totale 44.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.244
SG - Singapore 5.764
IE - Irlanda 2.054
UA - Ucraina 2.040
RU - Federazione Russa 1.763
BR - Brasile 1.688
IT - Italia 1.518
CN - Cina 1.508
SE - Svezia 1.482
HK - Hong Kong 1.287
VN - Vietnam 1.078
FR - Francia 774
DE - Germania 772
FI - Finlandia 659
GB - Regno Unito 414
KR - Corea 368
CA - Canada 271
IN - India 262
TR - Turchia 240
BD - Bangladesh 235
AR - Argentina 145
IQ - Iraq 136
MX - Messico 129
PL - Polonia 117
AT - Austria 100
ZA - Sudafrica 97
CH - Svizzera 92
PK - Pakistan 88
NL - Olanda 87
CO - Colombia 78
JP - Giappone 78
ES - Italia 76
EC - Ecuador 75
ID - Indonesia 73
UZ - Uzbekistan 73
VE - Venezuela 70
SA - Arabia Saudita 62
PH - Filippine 50
BE - Belgio 46
MA - Marocco 46
EE - Estonia 39
LB - Libano 35
PY - Paraguay 35
CZ - Repubblica Ceca 34
JM - Giamaica 32
GR - Grecia 31
KE - Kenya 30
MY - Malesia 29
CL - Cile 28
RO - Romania 25
TN - Tunisia 25
AE - Emirati Arabi Uniti 24
EG - Egitto 23
PE - Perù 21
CR - Costa Rica 18
LT - Lituania 18
UY - Uruguay 18
ET - Etiopia 17
KZ - Kazakistan 17
EU - Europa 15
JO - Giordania 15
AZ - Azerbaigian 14
LY - Libia 13
OM - Oman 13
IL - Israele 12
NP - Nepal 12
PA - Panama 12
TH - Thailandia 12
BO - Bolivia 11
DZ - Algeria 11
HN - Honduras 11
AU - Australia 10
RS - Serbia 10
BG - Bulgaria 9
KG - Kirghizistan 9
PS - Palestinian Territory 9
TW - Taiwan 9
AL - Albania 8
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
NI - Nicaragua 7
SN - Senegal 7
SV - El Salvador 7
GE - Georgia 6
KW - Kuwait 6
PR - Porto Rico 6
AM - Armenia 5
BB - Barbados 5
BN - Brunei Darussalam 5
HR - Croazia 5
IR - Iran 5
NG - Nigeria 5
PT - Portogallo 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
BS - Bahamas 4
DK - Danimarca 4
GA - Gabon 4
HU - Ungheria 4
Totale 43.977
Salva come PNG Salva come JPEG
Città #
Singapore 4.141
Chandler 2.286
Dublin 2.044
San Jose 1.591
Hong Kong 1.284
San Mateo 1.228
Ashburn 1.112
Jacksonville 844
Boardman 744
Santa Clara 738
Moscow 634
Dong Ket 622
Medford 548
Princeton 542
Altamura 518
Wilmington 500
Lauterbourg 495
Lawrence 383
Andover 345
Beijing 343
Ann Arbor 341
Perugia 325
Des Moines 319
Seoul 291
Los Angeles 249
New York 218
The Dalles 187
São Paulo 171
Saint Petersburg 165
Ho Chi Minh City 150
Helsinki 131
Izmir 120
Munich 117
Piscataway 116
Hanoi 99
Norwalk 96
Falls Church 95
Ottawa 85
Brooklyn 80
Dallas 79
Columbus 78
Orem 74
Shanghai 73
Warsaw 73
Tokyo 70
Woodbridge 64
Baghdad 63
Montreal 60
Council Bluffs 57
Houston 57
Rio de Janeiro 57
San Paolo di Civitate 57
Frankfurt am Main 56
Johannesburg 54
Chicago 52
Chennai 51
Phoenix 48
London 46
Nuremberg 46
Stockholm 46
Turku 46
Toronto 45
Brussels 44
Mexico City 40
Manchester 38
Vienna 38
Amsterdam 37
Buffalo 37
Tashkent 37
Redwood City 35
Rome 35
Curitiba 33
Redmond 33
Boston 32
Milan 32
Dhaka 31
Ankara 29
Denver 29
Quito 29
San Francisco 29
Seattle 29
Lahore 28
Poplar 27
Atlanta 26
Belo Horizonte 26
Auburn Hills 25
Den Haag 25
Dearborn 24
Guayaquil 24
Brasília 23
New Delhi 23
Jeddah 22
Nairobi 22
Naples 22
Da Nang 21
Hefei 21
Kingston 21
Porto Alegre 21
Riyadh 21
Salvador 21
Totale 26.739
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 192
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 165
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 151
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 149
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 148
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 148
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 144
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 142
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 141
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 137
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 136
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 136
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 135
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 135
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 135
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 133
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 131
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 131
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 129
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 129
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 128
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 128
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 126
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 126
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 126
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 125
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 123
Antiatherosclerotic effect of farnesoid X receptor. 123
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 123
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 123
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 122
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 122
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 121
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 120
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 120
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 119
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 118
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 118
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 117
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 116
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 116
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 114
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 114
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 114
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 114
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 113
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 111
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 111
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 110
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 110
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 110
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 110
A magic bullet for mucosal protection...and aspirin is the trigger! 110
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 109
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 109
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 109
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 109
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 109
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 107
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 106
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 106
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 106
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 106
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 106
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 106
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 106
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 105
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 105
D-2-antagonist levosulpiride inhibits afferent mediating perception of gastric distention in functional dyspepsia. 105
Abscess Formation In Hepatocellular-carcinoma - Complications of Percutaneous Ultrasound-guided Ethanol Injection 105
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 105
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 105
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 104
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 104
Bile Acid Signaling in Inflammatory Bowel Diseases 104
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents 103
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 103
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 103
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 103
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 103
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 103
Alkaline esophageal reflux- A misnomer 102
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 102
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 102
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 102
Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs. 101
Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells 101
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 101
.The vagal control of gallbladder motility is impaired in diabetics with autonomic neuropathy. 101
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 101
Primary brain abscess with Nocardia farcinica in an immunocompetent patient 101
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. A Review. 100
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 100
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 100
Bile Acids Activated Receptors in Inflammatory Bowel Disease 100
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. 99
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 99
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 98
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 98
Nitric oxide inhibits cathepsin B, UPA and plasmin activity via S-nitrosylation in vitro and in vivo. 98
Totale 11.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 214.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.232 0 816 68 233 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20242.407 206 312 144 50 35 21 464 146 162 94 412 361
2024/20256.875 69 695 224 227 902 284 247 602 1.423 456 1.066 680
2025/202614.534 1.059 898 860 1.698 1.799 1.247 2.610 769 1.709 1.233 407 245
2026/2027697 359 338 0 0 0 0 0 0 0 0 0 0
Totale 44.958